Steven R. Schow
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Steven R. Schow
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
27
| Extinct | Pharmaceuticals: Major | 27 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
8
| Extinct | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Steven R. Schow
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MABVAX THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Amygdala Neurosciences, Inc.
 Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of California, Davis | College/University | Graduate Degree Undergraduate Degree | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Founder | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| St. Mary's College of California | College/University | Corporate Officer/Principal Masters Business Admin | |
| Altair Capital Associates LLC | Founder Founder | ||
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Miscellaneous Commercial Services | Chief Operating Officer Corporate Officer/Principal | |
Xenerex Biosciences
 Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Xenerex Biosciences engages in developing and commercializing human antibody products to target antigens. The company was founded by John David Hansen and Wolfgang W. Scholz and is headquartered in Aliso Viejo, CA. | Miscellaneous Commercial Services | Founder Founder | |
| ARAVIVE, INC. | Biotechnology | Chief Executive Officer | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Christopher & Dana Reeve Foundation | Investment Trusts/Mutual Funds | Chairman | |
| Santa Clara University | College/University | Director/Board Member | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Aculys Pharma LLC
 Aculys Pharma LLC Pharmaceuticals: MajorHealth Technology Aculys Pharma LLC is a Japanese biopharmaceutical company that focuses on developing and commercializing innovations in the fields of neurology and psychiatry. The company is based in Japan and was established in January 2021. The company's philosophy is to act as a catalyst to access innovative medical care in the field of neuropsychiatry. Aculys Pharma develops and commercializes novel pharmaceuticals and provides innovations for better medical care to patients, their families, healthcare professionals, and society. | Pharmaceuticals: Major | Director/Board Member | |
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | Hospital/Nursing Management | Director/Board Member | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | Financial Conglomerates | Director/Board Member | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Founder | |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Director/Board Member | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
| Sofinnova Ventures | Corporate Officer/Principal | ||
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson. | Pharmaceuticals: Major | Director/Board Member | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Butitta Consulting Services LLC | Founder | ||
Catalyst Semiconductor, Inc.
 Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | Semiconductors | Director/Board Member | |
| Edgewood College | College/University | Undergraduate Degree | |
| ALZA Pharmaceuticals | Corporate Officer/Principal | ||
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Biotechnology | Director/Board Member | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member | |
| University of Oregon | College/University | Undergraduate Degree | |
| Kansas State University | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 49 |
| Japan | 3 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 13 |
| Health Services | 4 |
| Finance | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 141 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 55 |
| Director of Finance/CFO | 27 |
| Undergraduate Degree | 25 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jay Shepard | 30 |
| Mary Gray | 27 |
| Paul Maier | 25 |
| Dan Spiegelman | 25 |
| Stefan Ryser | 16 |
| Cynthia Butitta | 16 |
| Gregory P. Hanson | 15 |
| Graeme Martin | 15 |
| Robert W. Frick | 14 |
| Kenneth M. Cohen | 12 |
| Jeffrey V. Ravetch | 11 |
| Christopher Chai | 10 |
| Peter M. Strumph | 9 |
| Philip O. Livingston | 8 |
| Wolfgang W. Scholz | 8 |
- Börse
- Insiders
- Steven R. Schow
- Unternehmensverbindungen
